Summary
Of 17 patients with mild to moderate essential hypertension, 8 showed echocardiographic evidence of left ventricular hypertrophy. Cardiac and renal function evaluated by glomerular filtration rate (GFR) were studied in all patients before and after 20 weeks of quinapril treatment. Systolic pressure decreased from 174.7±16.7 to 131.7±7.7 mmHg (p<.0001) and diastolic pressure decreased from 101.8±9.8 to 80±4.3 mmHg (p<.0001). Left ventricular mass index decreased in the eight patients with left ventricular hypertrophy (p<.01). Basal values of GFR were lower than normal in 41% of all patients; GFR increased significantly after 20 weeks of treatment (from 96.5±32.3 to 108.6±31.12 ml/min, p<.01); it decreased in only one patient. Patients reported few adverse effects to quinapril, and no important clinical laboratory abnormality was observed. Quinapril not only lowered arterial pressure, but it had a distinct effect on regression of left ventricular hypertrophy and favorable effects on renal function.
Similar content being viewed by others
References
Dzau VI. Quinapril—a new angiotensin-converting enzyme inhibitor: An overview.Angiology 1989;40:329–330.
Zusman RM. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.Kidney Int 1984;25:969–983.
Todd PA, Heel RC. Enalapril: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs 1986;31:198–248.
Ryan MJ, Boucher DM, Cohen DM, et al. Antihypertensive profile of the angiotensin-converting enzyme inhibitors. CI-906 and CI-907.Fed Proc 1984;43:1330–2.
Saynavalammi P, Porsti I, Nurmi A-K, et al. Inhibition of angiotensin-converting enzyme with quinapril (C-906): Investigation of antihypertensive mechanism in spontaneously hypertensive rats.J Pharmacol Exp Ther 1986;237:246–251.
Gavras I, Vlahakos D, Melby JC, Gavras H. Pilot study of the effects of the angiotensin-converting enzyme inhibitor CI-906 on patients with essential hypertension.J Clin Pharmacol 1984;24:343–350.
Investigator's Brochure. Warner-Lambert/Parke-Davis Co. Ann Arbor, Michigan, 1986.
Kirkendall WM, Burton MC, Epstein FM, Freis ED. Recommendation for human blood pressure determinations by sphygmomanometers.Circulation 1967;36:980–988.
Dunn FG, Chandraratna P, De Carvalho JGR, Basta LL, Frohlic ED. Pathophysiologic assessment of hypertensive heart disease with echocardiography.Am J Cardiol 1977;75:789–795.
Levy D, Savage DD, Garrison RJ, et al. Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study.Am J Cardiol 1987;59:956–960.
Sagn DJ, de Maria A, Kisslo J, Weymann A. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiography measurements.Circulation 1977;58:1072–1083.
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation 1977;55:613–618.
Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements.J Am Coll Cardiol 1984;4:1222–1230.
Gates GF. Glomerular filtration rate: Estimation from fractional renal accumulation of Tc-99m DTPA (stannous).Am J Roentgenol 1982;138:565–570.
Gates GF. Split renal function testing using Tc-99m DTPA. A rapid technique for determining differential glomerular filtration.Clin Nucl Med 1983;8:400–407.
Armitage P.Statistical Methods in Medical Research. New York: Blackwell Scientific Publications, 1971.
Dzau VJ. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors.Am J Med 1988;84:4–8.
Mimran A, Ribstein J. Angiotensin converting enzyme inhibit and renal function.J Hypertens 1989;7(Suppl 5):S3-S9.
Bauer JH, Reams GP: The effects of angiotensin converting enzyme inhibitors in hypertension.Am J Med 1986;81(Suppl 4C):S6-S14.
Bauer JH, Reams GP: The effects of antihypertensive therapy on renal function. In: Brenner BM, Laragh JH, Kaplan NM, eds.Perspectives on Hypertension, Vol. 3: New Therapeutic Strategies for Hypertension. New York, Raven Press, 1989:253–287.
Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissue from spontaneously hypertensive rats after treatment with captopril or MK-421.J Pharmacol Exp Ther 1982;220:63–69.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Caprio, L., De Rosa, M.L., Di Palma, A. et al. Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril. Cardiovasc Drug Ther 8, 735–740 (1994). https://doi.org/10.1007/BF00877120
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00877120